View source for Sumitomo Pharma Co., Ltd. (20250084411). Antisense Nucleic Acid

=Antisense Nucleic Acid=


==Organization Name==

[[:Category:Sumitomo Pharma Co., Ltd.|Sumitomo Pharma Co., Ltd.]]


[[Category:Sumitomo Pharma Co., Ltd.]]

==Inventor(s)==

[[:Category:Zhiqiu Man of Osaka shi, Osaka (JP)|Zhiqiu Man of Osaka shi, Osaka (JP)]][[Category:Zhiqiu Man of Osaka shi, Osaka (JP)]]

[[:Category:Shigehiro Asano of Osaka-shi, Osaka (JP)|Shigehiro Asano of Osaka-shi, Osaka (JP)]][[Category:Shigehiro Asano of Osaka-shi, Osaka (JP)]]

[[:Category:Kyosuke Hino of Osaka-shi, Osaka (JP)|Kyosuke Hino of Osaka-shi, Osaka (JP)]][[Category:Kyosuke Hino of Osaka-shi, Osaka (JP)]]

==Antisense Nucleic Acid==


This abstract first appeared for US patent application 20250084411 titled 'Antisense Nucleic Acid

==Original Abstract Submitted==

the present disclosure relates to an oligonucleotide that expresses functional human wrn protein against skip mutation in the 26th or 28th exon of human wrn gene, or a pharmaceutically acceptable salt thereof, and use thereof.



[[Category:C12N15/113]]
[[Category:CPC_C12N15/113]]